米诺地尔（Minoxidil） 用于 雄激素性脱发

References

1. [1] Larissa Pierri Carvalho Fonseca et al.. J Am Acad Dermatol. 2026. Oral minoxidil 2.5 mg versus 5 mg for male androgenetic alopecia: A double-blind randomized clinical trial. doi:10.1016/j.jaad.2025.09.031 PubMed
2. [2] Christopher J Thang et al.. J Am Acad Dermatol. 2026. Cardiovascular safety of low-dose oral minoxidil in nonscarring alopecia: A multicenter population-based cohort study using TriNetX. doi:10.1016/j.jaad.2025.08.079 PubMed
3. [3] Michael M Ong et al.. Am J Clin Dermatol. 2026. Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations. doi:10.1007/s40257-025-00990-4 PubMed
4. [4] Junying Zhang et al.. Adv Healthc Mater. 2026. Natural Sweetener Stevioside-Based Dissolving Microneedles Solubilize Minoxidil for the Treatment of Androgenic Alopecia. doi:10.1002/adhm.202503575 PubMed
5. [5] Ngoc-Trinh Tran et al.. Biomaterials. 2026. A novel cell-free regenerative therapy for hair loss: human fetal cartilage progenitor cell secretome. doi:10.1016/j.biomaterials.2025.123627 PubMed
6. [6] Guorui Li et al.. J Cosmet Dermatol. 2026. Clinical Efficacy and Mechanisms of Microneedling Alone or Combined With Drugs in the Treatment of Androgenetic Alopecia. doi:10.1111/jocd.70726 PubMed
7. [7] Jinfeng Fu et al.. Food Res Int. 2026. Lactiplantibacillus plantarum ZJUIDS51 improves androgenic alopecia via gut-skin axis. doi:10.1016/j.foodres.2026.118793 PubMed
8. [8] Zetian Zhong et al.. J Cosmet Dermatol. 2026. Research Progress on Platelet-Rich Plasma (PRP) in the Treatment of Androgenetic Alopecia. doi:10.1111/jocd.70809 PubMed
9. [9] Jacob Beer et al.. Dermatol Surg. 2026. Injectable Therapy for Androgenetic Alopecia: A Systematic Review. doi:10.1097/DSS.0000000000004999 PubMed
10. [10] Jiaxue Zhang et al.. Adv Healthc Mater. 2026. Chitin Derivative-Based Detachable Microneedles for Effective Treatment of Androgenic Alopecia. doi:10.1002/adhm.202504691 PubMed
11. [11] Daniel Ramos-Rodriguez et al.. Dermatol Ther (Heidelb). 2026. Characterization and Management of Androgenetic Alopecia in Transgender and Gender-Diverse Individuals: A Narrative Review. doi:10.1007/s13555-026-01735-9 PubMed
12. [12] Caitlin A Kearney et al.. Am J Clin Dermatol. 2026. Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments. doi:10.1007/s40257-026-01009-2 PubMed
13. [13] Zachary J K Neubauer et al.. J Am Acad Dermatol. 2026. Minoxidil's pulse check. doi:10.1016/j.jaad.2025.11.099 PubMed
14. [14] Aditya K Gupta et al.. Expert Opin Pharmacother. 2026. Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern Hair loss in Hair transplant … doi:10.1080/14656566.2026.2642216 PubMed
15. [15] Yikun Shang et al.. ACS Appl Mater Interfaces. 2026. Microneedle-Based Codelivery of Platycladus orientalis-Derived Extracellular Vesicles and Minoxidil Nanoparticles for Androgenetic Alopecia Treatment. doi:10.1021/acsami.6c03910 PubMed
16. [16] Jovian Wan et al.. Aesthetic Plast Surg. 2025. A Prospective Study of Exosome Therapy for Androgenetic Alopecia. doi:10.1007/s00266-025-04817-9 PubMed
17. [17] Zheng Xing et al.. Acta Biomater. 2025. Microenvironment-responsive recombinant collagen XVII-based composite microneedles for the treatment of androgenetic alopecia. doi:10.1016/j.actbio.2025.05.039 PubMed
18. [18] Jair Alejandro Valdez-Zertuche et al.. Expert Opin Drug Metab Toxicol. 2025. Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review. doi:10.1080/17425255.2025.2461483 PubMed
19. [19] Jayanaraian F M Andrade et al.. Expert Opin Drug Deliv. 2025. An update on nanocarriers for follicular-targeted drug delivery for androgenetic alopecia topical treatment. doi:10.1080/17425247.2025.2457950 PubMed
20. [20] Michael M Ong et al.. J Am Acad Dermatol. 2025. Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current and emerging therapies. doi:10.1016/j.jaad.2025.04.074 PubMed
21. [21] Yukun Liu et al.. Front Bioeng Biotechnol. 2025. Subcutaneous injection of genetically engineered exosomes for androgenic alopecia treatment. doi:10.3389/fbioe.2025.1614090 PubMed
22. [22] Elise A Olsen et al.. J Am Acad Dermatol. 2025. Summation and recommendations for the safe and effective use of topical and oral minoxidil. doi:10.1016/j.jaad.2025.04.016 PubMed
23. [23] Aditya K Gupta et al.. PLoS One. 2025. Epidemiological landscape of androgenetic alopecia in the US: An All of Us cross-sectional study. doi:10.1371/journal.pone.0319040 PubMed
24. [24] Gabriel Lazzeri Cortez et al.. An Bras Dermatol. 2025. Male androgenetic alopecia. doi:10.1016/j.abd.2024.08.004 PubMed
25. [25] Shuting Chen et al.. Drug Des Devel Ther. 2025. Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment. doi:10.2147/DDDT.S542000 PubMed
26. [26] Yujun Shan et al.. Int J Pharm. 2025. Liposomes enhance the hair follicle delivery of minoxidil sulfate with improved treatment of androgenic alopecia. doi:10.1016/j.ijpharm.2025.125642 PubMed
27. [27] Changpei Lu et al.. Regen Ther. 2025. Platelet-rich plasma-derived exosomes stimulate hair follicle growth through activation of the Wnt/β-Catenin signaling pathway. doi:10.1016/j.reth.2025.04.003 PubMed
28. [28] Sarah Schaffer et al.. Cureus. 2025. A Scoping Review of Exosome Delivery Applications in Hair Loss. doi:10.7759/cureus.81152 PubMed
29. [29] Khalid M A Ahmed et al.. Arch Dermatol Res. 2025. Evaluating the efficacy and safety of combined microneedling therapy versus topical Minoxidil in androgenetic alopecia: a systematic review and meta-analysis. doi:10.1007/s00403-025-04032-1 PubMed
30. [30] Hans Johnson et al.. Cureus. 2025. Effectiveness of Combined Oral Minoxidil and Finasteride in Male Androgenetic Alopecia: A Retrospective Service Evaluation. doi:10.7759/cureus.77549 PubMed
31. [31] Ziyi Liu et al.. Int J Pharm. 2025. Co-delivery of minoxidil and finasteride via ionic liquid and cyclodextrin-assisted in situ thermosensitive hydrogel for synergistic treatment of androgenic alopecia. doi:10.1016/j.ijpharm.2025.125263 PubMed
32. [32] Ping Xue et al.. J Cosmet Dermatol. 2025. A Prospective and Comparative Study to Explore the Effects of Platelet-Rich Plasma in Hair Transplantation for Patients With Androgenetic Alopecia. doi:10.1111/jocd.16665 PubMed
33. [33] Rúben Lopes-Silva et al.. Cureus. 2025. Platelet-Rich Plasma Effectiveness in Treating Androgenetic Alopecia: A Comprehensive Evaluation. doi:10.7759/cureus.77371 PubMed
34. [34] Jayanaraian F M Andrade et al.. Ther Deliv. 2025. Topical dutasteride for androgenic alopecia: current state and prospects. doi:10.1080/20415990.2024.2437973 PubMed
35. [35] Edward H Reynolds et al.. Eur J Clin Nutr. 2025. Fortification, folate and vitamin B12 balance, and the nervous system. Is folic acid excess potentially harmful? doi:10.1038/s41430-025-01652-8 PubMed
36. [36] Jia Zhi et al.. J Med Chem. 2025. Wnt/β-Catenin Signaling Pathway Targeting Androgenetic Alopecia: How Far Can We Go Beyond Minoxidil and Finasteride? doi:10.1021/acs.jmedchem.5c02108 PubMed
37. [37] Kawthar K Abla et al.. Int J Nanomedicine. 2025. Alopecia Management Potential of Rosemary-Based Nanoemulgel Loaded with Metformin: Approach Combining Active Essential Oil and Repurposed Drug. doi:10.2147/IJN.S500487 PubMed
38. [38] Milene Vitória Sampaio Sobral et al.. Int J Dermatol. 2025. Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta-analysis of randomized clinical trials. doi:10.1111/ijd.17524 PubMed
39. [39] Alexandra Junge et al.. Acta Derm Venereol. 2025. Contact Dermatitis Caused by Topical Minoxidil: Allergy or Just Irritation. doi:10.2340/actadv.v105.42401 PubMed
40. [40] Aditya K Gupta et al.. Expert Opin Pharmacother. 2025. Efficacy and safety of dutasteride in the treatment of alopecia: a comprehensive review. doi:10.1080/14656566.2025.2461169 PubMed
41. [41] Guilherme Kuceki et al.. JAAD Int. 2025. Enhanced hair regrowth with five monthly sessions of minoxidil-dutasteride-copper peptides tattooing for androgenetic alopecia assessed by artificial intelligence and blinded … doi:10.1016/j.jdin.2025.01.012 PubMed
42. [42] Funda Koç Babayiğit et al.. J Dermatolog Treat. 2025. Effects of platelet-rich plasma application on hair follicle count, telogen/anagen ratio, and miniaturized hair ratio in patients with androgenic alopecia: … doi:10.1080/09546634.2025.2528343 PubMed
43. [43] Zhengxin Suo et al.. Drug Deliv Transl Res. 2025. Application of platelet-rich plasma lysate combined with hyaluronic acid microneedles for the treatment of alopecia. doi:10.1007/s13346-025-01816-w PubMed
44. [44] Pimpakarn Werachattawatchai et al.. Int J Womens Dermatol. 2025. Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a randomized, double-blind, placebo-controlled, parallel-group pilot … doi:10.1097/JW9.0000000000000227 PubMed
45. [45] Shuqi Chen et al.. Eur J Dermatol. 2025. Research progress on the pathogenesis of androgenetic alopecia. doi:10.1684/ejd.2025.4815 PubMed
46. [46] Tyan Shin Lee et al.. J Am Acad Dermatol. 2025. An international multicenter, retrospective cohort study of 203 patients with pediatric androgenetic alopecia. doi:10.1016/j.jaad.2025.02.002 PubMed
47. [47] Abdulmajeed Alosaimi et al.. J Dermatolog Treat. 2025. Comparative efficacy of minoxidil alone versus minoxidil combined with low-level laser therapy in the treatment of androgenic alopecia: a systematic … doi:10.1080/09546634.2024.2447355 PubMed
48. [48] Lili Legiawati et al.. Arch Dermatol Res. 2025. Hair regeneration in androgenetic alopecia using secretome of adipose-derived stem cells (ADSC) and minoxidil: a comparative study of three groups. doi:10.1007/s00403-025-04006-3 PubMed
49. [49] Baltazar Sanabria et al.. J Eur Acad Dermatol Venereol. 2025. Sublingual Minoxidil 5 mg versus Oral Minoxidil 5 mg for male androgenetic alopecia: A double-blind randomized clinical trial. doi:10.1111/jdv.20508 PubMed
50. [50] Ambika Nohria et al.. J Am Acad Dermatol. 2025. Treatment of androgenetic alopecia with low-dose oral minoxidil monotherapy compared with combination therapy with dutasteride or finasteride. doi:10.1016/j.jaad.2025.01.067 PubMed
51. [51] Xuexue Pan et al.. Aesthetic Plast Surg. 2025. Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation. doi:10.1007/s00266-025-05077-3 PubMed
52. [52] Farah Faulin Lubis et al.. Arch Dermatol Res. 2025. Randomized controlled trial on the efficacy and safety of the combination therapy of topical 0.1% finasteride - 5% Minoxidil in … doi:10.1007/s00403-025-04216-9 PubMed
53. [53] Huixing Zhang et al.. Phytomedicine. 2025. Shen-Ying-Yang-Zhen formula promotes angiogenesis around hair follicles, alleviates oxidative stress, and inhibits hair follicle apoptosis through the VEGF/Akt/Caspase-9 signaling axis. doi:10.1016/j.phymed.2025.156963 PubMed
54. [54] Zachary J K Neubauer et al.. J Am Acad Dermatol. 2025. No association between low-dose oral minoxidil and tachycardia in a large retrospective cohort study of patients with non-scarring alopecia. doi:10.1016/j.jaad.2025.07.065 PubMed
55. [55] Jia Zhang et al.. J Affect Disord. 2025. Dietary food folate and synthetic folic acid co-exposure patterns with elevated depressive symptoms: Findings from NHANES 2005-2018. doi:10.1016/j.jad.2025.03.191 PubMed
56. [56] Laxmi Iyengar et al.. Aust Prescr. 2025. Male and female pattern hair loss. doi:10.18773/austprescr.2025.020 PubMed
57. [57] Leo L Wang et al.. ACS Biomater Sci Eng. 2025. Controlled Release of Minoxidil through Hydrogel Cross-Linking to Treat Androgenetic Alopecia. doi:10.1021/acsbiomaterials.5c00292 PubMed
58. [58] Nermeen Ibrahim Bedair et al.. Clin Exp Dermatol. 2025. Efficacy and safety of combined topical estradiol with minoxidil vs. topical minoxidil in female pattern hair loss: a trichoscopic randomized … doi:10.1093/ced/llae436 PubMed
59. [59] Ricardo da Silva Libório et al.. JAAD Int. 2025. Bicalutamide 25 mg combined with minoxidil 1 mg versus minoxidil 1 mg for female pattern hair loss: A randomized double-blind … doi:10.1016/j.jdin.2024.12.002 PubMed
60. [60] Ian Landells et al.. J Cutan Med Surg. 2025. A Canadian Consensus on Androgenetic Alopecia: Approach and Management. doi:10.1177/12034754251368849 PubMed
61. [61] Rui-Xian Guo et al.. Front Pharmacol. 2025. Research progress in the treatment of non-scarring alopecia: mechanism and treatment. doi:10.3389/fphar.2025.1544068 PubMed
62. [62] Luis A Mendoza et al.. Cureus. 2025. Comprehensive Review on Hair Loss and Restorative Techniques: Advances in Diagnostic, Artistry, and Surgical Innovation. doi:10.7759/cureus.82991 PubMed
63. [63] Ahmed Abdulhussein Kawen. Acta Dermatovenerol Alp Pannonica Adriat. 2025. Effects of oral minoxidil on serum VEGF and hair regrowth in androgenetic alopecia. PubMed
64. [64] Xiaojin Wu et al.. Arch Dermatol Res. 2025. Analysis on the treatment compliance of patients with androgenetic alopecia and its influencing factors: based on the comparison between microneedle … doi:10.1007/s00403-025-04211-0 PubMed
65. [65] P Janaani et al.. Arch Dermatol Res. 2025. Analysing efficacy of low-dose oral minoxidil, topical minoxidil, and platelet-rich plasma with topical minoxidil combination in patients with androgenetic alopecia: … doi:10.1007/s00403-025-03938-0 PubMed
66. [66] Aditya K Gupta et al.. J Cosmet Dermatol. 2025. Comparative Efficacy of Minoxidil and 5-Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta-Analysis Study of Current Empirical … doi:10.1111/jocd.70320 PubMed
67. [67] Fan Qi et al.. ACS Appl Mater Interfaces. 2025. Plant Nanovesicles Integrate Bioactivity and Transdermal Finasteride Delivery for Androgenetic Alopecia. doi:10.1021/acsami.5c15594 PubMed
68. [68] Yanhua Li et al.. J Am Acad Dermatol. 2025. Therapeutic efficacy of platelet-rich plasma combining with microneedling and topical minoxidil in refractory severe androgenic alopecia. doi:10.1016/j.jaad.2024.10.046 PubMed
69. [69] O M Moreno-Arrones et al.. Actas Dermosifiliogr. 2025. [Translated article] High-dose Oral Minoxidil for the Treatment of Androgenetic Alopecia. doi:10.1016/j.ad.2025.05.018 PubMed
70. [70] Aditya K Gupta et al.. Skin Appendage Disord. 2025. Do Non-Prescription Products Help in Managing Androgenic Alopecia? doi:10.1159/000542880 PubMed
71. [71] Denise Ferreira Rodrigues et al.. Lasers Med Sci. 2025. Photobiomodulation therapy and 5% minoxidil in female pattern hair loss: a case series focusing on hair growth phases over a … doi:10.1007/s10103-025-04780-6 PubMed
72. [72] Ferra Olivia Mawu et al.. Lasers Med Sci. 2025. Comparative efficacy and safety of low-level laser therapy and topical Minoxidil combination vs. topical Minoxidil monotherapy in androgenetic alopecia management: … doi:10.1007/s10103-025-04593-7 PubMed
73. [73] Yinfeng Xia et al.. Front Med (Lausanne). 2025. Relative efficacy of minoxidil in combination with other treatments for androgenic alopecia: a network meta-analysis based on randomized controlled trials. doi:10.3389/fmed.2025.1638496 PubMed
74. [74] Naglaa Mohamad Al Sayed et al.. Dermatol Pract Concept. 2025. Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment. doi:10.5826/dpc.1501a4698 PubMed
75. [75] Nghiem H Nguyen et al.. J Plast Reconstr Aesthet Surg. 2025. Estrogen hormone therapy stabilizes lateral hairline in transfeminine patients: Implications for facial feminization surgery. doi:10.1016/j.bjps.2024.07.044 PubMed
76. [76] Eliza Balazic et al.. J Drugs Dermatol. 2025. Concurrent Lichen Planopilaris and Female Androgenic Alopecia in Skin of Color: A Case Series. doi:10.36849/JDD.7318 PubMed
77. [77] Sherif A Kamar et al.. Cells Tissues Organs. 2025. Exploring Mesenchymal Stem Cells versus Minoxidil for Androgenic Alopecia Treatment: A Detailed Animal-Based Histological and Morphometric Study. doi:10.1159/000542547 PubMed
78. [78] Daniella Kushnir-Grinbaum et al.. J Am Acad Dermatol. 2025. Continued year-on-year improvement in hair density with systemic minoxidil in women with female pattern hair loss: A case series. doi:10.1016/j.jaad.2025.03.028 PubMed
79. [79] Rajah Darwish et al.. Cureus. 2025. From Cells to Strands: A Systematic Review Comparing Exosome Therapy, Platelet-Rich Plasma, and Minoxidil for Androgenetic Alopecia Treatment. doi:10.7759/cureus.87875 PubMed
80. [80] Ana Melián-Olivera et al.. J Clin Med. 2025. Frontal Fibrosing Alopecia in Men: A Review of the Literature. doi:10.3390/jcm14061914 PubMed
81. [81] Carli D Needle et al.. Int J Dermatol. 2025. Alopecia Treatments in Breastfeeding: Safety and Clinical Considerations. doi:10.1111/ijd.17940 PubMed
82. [82] Massimo Milani et al.. J Cosmet Dermatol. 2025. Impact of a Novel Dietary Supplement on Efficacy of Pharmacological Treatments for Androgenic Alopecia: A Real-Life, Multicenter, Randomized, Assessor-Blinded Trial … doi:10.1111/jocd.70388 PubMed
83. [83] Rocío Gil-Redondo et al.. JAAD Int. 2025. Improvement of female pattern hair loss with bicalutamide: A time-dependent process. doi:10.1016/j.jdin.2025.07.008 PubMed
84. [84] Aditya K Gupta et al.. J Cosmet Dermatol. 2025. Relative Efficacy of Conventional Monotherapies and Select Nonconventional, Over-the-Counter Products for Male Androgenetic Alopecia: A Network Meta-Analysis Study. doi:10.1111/jocd.70483 PubMed
85. [85] Yan Chang et al.. Arch Dermatol Res. 2025. Clinical efficacy of microneedle combined with 5% Minoxidil solution and finasteride in the treatment of androgenetic alopecia in males. doi:10.1007/s00403-025-03891-y PubMed
86. [86] Jung-Won Shin et al.. Ann Dermatol. 2025. Updates in Treatment for Androgenetic Alopecia. doi:10.5021/ad.25.042 PubMed
87. [87] Yingzi Liu et al.. Nat Rev Dis Primers. 2025. Androgenetic alopecia. doi:10.1038/s41572-025-00656-9 PubMed
88. [88] Jovian Wan et al.. J Craniofac Surg. 2025. Comparative Efficacy of Topical Chitosan and Minoxidil in Hair Loss: A Controlled Study With Microneedling. doi:10.1097/SCS.0000000000012051 PubMed
89. [89] Lei Zhou et al.. Front Nutr. 2025. Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis. doi:10.3389/fnut.2025.1719711 PubMed
90. [90] C D Villarreal-Villarreal et al.. Actas Dermosifiliogr. 2025. Low-Dose Oral Minoxidil as Treatment for COVID-19-Related Telogen Effluvium: Results From a Retrospective Series of 69 Patients. doi:10.1016/j.ad.2025.104569 PubMed
91. [91] Aliyyat Afolabi et al.. Telemed Rep. 2025. Asynchronous Teledermatology for Non-Scarring Alopecia: A Retrospective Study. doi:10.1177/26924366251366793 PubMed
92. [92] Alondra Saray Polanco-Llanes et al.. Cureus. 2025. Plica Neuropathica (Polonica) Secondary to Diffuse Alopecia: A Case Report and Literature Review. doi:10.7759/cureus.93402 PubMed
93. [93] Flávia Machado Alves Basilio et al.. Arch Dermatol Res. 2025. Blood pressure changes in patients after Minoxidil microinfusion to treat female pattern alopecia: analysis of a randomized, single blinded, placebo … doi:10.1007/s00403-025-04247-2 PubMed
94. [94] Anurak Muangsanguan et al.. Foods. 2025. Anti-Hair Loss Potential of Perilla Seed Extracts: In Vitro Molecular Insights from Supercritical Fluid Extraction. doi:10.3390/foods14152583 PubMed
95. [95] Yanhua Li et al.. J Am Acad Dermatol. 2025. Response to Pavlović's "Response to Li et al.'s 'Therapeutic efficacy of platelet-rich plasma combining with microneedling and topical minoxidil in … doi:10.1016/j.jaad.2025.08.056 PubMed
96. [96] Tao Ye et al.. Regen Biomater. 2025. Engineered collagen XVII-loaded dissolving microneedle patch for promoting hair regrowth in androgenic alopecia. doi:10.1093/rb/rbaf104 PubMed
97. [97] Miloš D Pavlović. J Am Acad Dermatol. 2025. Response to Li et al's "Therapeutic efficacy of platelet-rich plasma combining with microneedling and topical minoxidil in refractory severe androgenic … doi:10.1016/j.jaad.2025.05.1463 PubMed
98. [98] Yating Dong et al.. J Nanobiotechnology. 2025. Rejuvenating senescent hair follicles: a novel conjugated linoleic acid based nanovesicle approach to treat androgenic alopecia. doi:10.1186/s12951-025-03865-2 PubMed
99. [99] Carolina Schettino Kegele et al.. Int J Pharm Compd. 2025. Personalized Compounded Hair Loss Treatments: A Compatibility Assessment of the TrichoConcept™ Vehicle Line. PubMed
100. [100] Nicole Yoong et al.. J Am Acad Dermatol. 2025. Combination of oral minoxidil and bicalutamide for the treatment of female pattern hair loss in adolescents. doi:10.1016/j.jaad.2025.01.056 PubMed
101. [101] Rachita Dhurat et al.. J Cosmet Dermatol. 2025. Real-World Efficacy and Safety of Cuticapil Stem Hair Serum as an Add-On to Minoxidil in Androgenetic Alopecia: A Prospective Observational … doi:10.1111/jocd.70247 PubMed
102. [102] Sara M Mohy et al.. Clin Cosmet Investig Dermatol. 2025. Consensus Recommendations for the Management of Androgenetic Alopecia in Egypt: A Modified Delphi Study. doi:10.2147/CCID.S556881 PubMed
103. [103] Adal Mena-García et al.. Molecules. 2025. Kyoh® Rocket Leaf Extract Regulates Proliferation and VEGF and FGF7 Expression in Human Dermal Follicle Papilla Cells. doi:10.3390/molecules30071489 PubMed
104. [104] Robert J Vanaria et al.. J Cosmet Dermatol. 2025. The Use of Light-Based Therapies in the Treatment of Alopecia. doi:10.1111/jocd.70434 PubMed
105. [105] Ghada Fawzy Rezk Hassan et al.. Int J Trichology. 2025. Evaluation of the Efficacy and Safety of Topical Spironolactone versus Topical Minoxidil in the Treatment of Female Pattern Hair Loss: … doi:10.4103/ijt.ijt_118_23 PubMed
106. [106] Adam Leavitt et al.. J Drugs Dermatol. 2025. Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions. doi:10.36849/JDD.8763 PubMed
107. [107] Carli D Needle et al.. Arch Dermatol Res. 2025. Key considerations of injectable minoxidil for alopecia. doi:10.1007/s00403-025-04068-3 PubMed
108. [108] Muhammad Umar et al.. Aesthetic Plast Surg. 2025. Comparative Efficacy and Safety of Platelet Rich Plasma (PRP) versus Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis. doi:10.1007/s00266-025-05394-7 PubMed
109. [109] Chanda Dubey et al.. Ann Maxillofac Surg. 2025. Efficiency of 5% Minoxidil and Platelet-rich Plasma Therapy in Androgenetic Alopecia - A Retrospective Study. doi:10.4103/ams.ams_168_24 PubMed
110. [110] Mariana Alvares Penha et al.. JAMA Dermatol. 2024. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial. doi:10.1001/jamadermatol.2024.0284 PubMed
111. [111] Dan Liu et al.. Int J Med Sci. 2024. Status of research on the development and regeneration of hair follicles. doi:10.7150/ijms.88508 PubMed
112. [112] Xiaochuan Wu et al.. J Control Release. 2024. Hybrid hair follicle stem cell extracellular vesicles co-delivering finasteride and gold nanoparticles for androgenetic alopecia treatment. doi:10.1016/j.jconrel.2024.07.066 PubMed
113. [113] Ali Asilian et al.. J Cosmet Dermatol. 2024. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled … doi:10.1111/jocd.16086 PubMed
114. [114] Qin Yang et al.. Regen Biomater. 2024. Dissolvable microneedles loaded ginsenoside Rg3 liposome: a transdermal delivery approach for alopecia treatment. doi:10.1093/rb/rbae086 PubMed
115. [115] Jie Gao et al.. Adv Healthc Mater. 2024. Traditional Scraping (Gua Sha) Combined with Copper-Curcumin Nanoparticle Oleogel for Accurate and Multi-Effective Therapy of Androgenic Alopecia. doi:10.1002/adhm.202303095 PubMed
116. [116] Alfredo Rossi et al.. J Cosmet Dermatol. 2024. Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic … doi:10.1111/jocd.15953 PubMed
117. [117] Promise Ufomadu. Proc (Bayl Univ Med Cent). 2024. Complementary and alternative supplements: a review of dermatologic effectiveness for androgenetic alopecia. doi:10.1080/08998280.2023.2263829 PubMed
118. [118] Ilakkia Priya Sadasivam et al.. Indian J Dermatol. 2024. Androgenetic Alopecia in Men: An Update On Genetics. doi:10.4103/ijd.ijd_729_23 PubMed
119. [119] Afsaneh Sadeghzadeh Bazargan et al.. J Cosmet Dermatol. 2024. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral … doi:10.1111/jocd.15979 PubMed
120. [120] Mohammad Amin Jafari et al.. Health Sci Rep. 2024. Efficacy and Safety of Laser Therapy and Phototherapy in Cicatricial and NonCicatricial Alopecia: A Systematic Review Study. doi:10.1002/hsr2.70180 PubMed
121. [121] Yuyang Gan et al.. Plast Reconstr Surg. 2024. A Clinical Trial of Treating Androgenic Alopecia with Mesenchymal Stem Cell Suspension Derived from Autologous Hair Follicle. doi:10.1097/PRS.0000000000010841 PubMed
122. [122] Muhammad Awais Anjum et al.. Front Pharmacol. 2024. Stimulation of hair regrowth in an animal model of androgenic alopecia using 2-deoxy-D-ribose. doi:10.3389/fphar.2024.1370833 PubMed
123. [123] Amanda Rosenthal et al.. J Cosmet Laser Ther. 2024. Management of androgenic alopecia: a systematic review of the literature. doi:10.1080/14764172.2024.2362126 PubMed
124. [124] Juan Jimenez-Cauhe et al.. J Cosmet Dermatol. 2024. Hair follicle sulfotransferase activity and effectiveness of oral minoxidil in androgenetic alopecia. doi:10.1111/jocd.16473 PubMed
125. [125] Siddhi Bianca Camila Lama et al.. J Clin Med. 2024. Physical Treatments and Therapies for Androgenetic Alopecia. doi:10.3390/jcm13154534 PubMed
126. [126] Eliza Balazic et al.. Lasers Med Sci. 2024. The role of laser and energy-assisted drug delivery in the treatment of alopecia. doi:10.1007/s10103-024-04015-0 PubMed
127. [127] Bjad K Almutairy et al.. Int J Pharm X. 2024. Spanlastic-laden nanogel as a plausible platform for dermal delivery of bimatoprost with superior cutaneous deposition and hair regrowth efficiency in … doi:10.1016/j.ijpx.2024.100240 PubMed
128. [128] Jiratchaya Tantiyavarong et al.. Photodermatol Photoimmunol Photomed. 2024. Red and Green LED Light Therapy: A Comparative Study in Androgenetic Alopecia. doi:10.1111/phpp.13004 PubMed
129. [129] Ratchathorn Panchaprateep. Facial Plast Surg. 2024. Medical Treatment for Androgenetic Alopecia. doi:10.1055/a-2196-4713 PubMed
130. [130] MaryAnn Dakkak et al.. Am Fam Physician. 2024. Hair Loss: Diagnosis and Treatment. PubMed
131. [131] Aditya K Gupta et al.. Expert Opin Emerg Drugs. 2024. Emerging and traditional 5-α reductase inhibitors and androgen receptor antagonists for male androgenetic alopecia. doi:10.1080/14728214.2024.2346590 PubMed
132. [132] Aditya K Gupta et al.. J Cosmet Dermatol. 2024. The impact of monotherapies for male androgenetic alopecia: A network meta-analysis study. doi:10.1111/jocd.16362 PubMed
133. [133] Aditya K Gupta et al.. Expert Opin Pharmacother. 2024. Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia. doi:10.1080/14656566.2024.2314087 PubMed
134. [134] Nouf F Bin Rubaian et al.. Clin Cosmet Investig Dermatol. 2024. An Overview of Commonly Used Natural Alternatives for the Treatment of Androgenetic Alopecia, with Special Emphasis on Rosemary Oil. doi:10.2147/CCID.S470989 PubMed
135. [135] Lifang Hu et al.. Skin Res Technol. 2024. Efficacy and safety of botulinum toxin A in the treatment of female pattern hair loss. doi:10.1111/srt.13696 PubMed
136. [136] Xiaxia Liu et al.. Int J Pharm. 2024. Synergistic therapeutic effect of ginsenoside Rg3 modified minoxidil transfersomes (MXD-Rg3@TFs) on androgenic alopecia in C57BL/6 mice. doi:10.1016/j.ijpharm.2024.123963 PubMed
137. [137] Aditya K Gupta et al.. J Cosmet Dermatol. 2024. The relative effect of monotherapy with 5-alpha reductase inhibitors and minoxidil for female pattern hair loss: A network meta-analysis study. doi:10.1111/jocd.15910 PubMed
138. [138] Ramadan S Hussein et al.. Skin Health Dis. 2024. Applications and efficacy of minoxidil in dermatology. doi:10.1002/ski2.472 PubMed
139. [139] Shuxuan Li et al.. Int J Pharm. 2024. Panax notoginseng saponins loaded W/O microemulsion for alopecia therapy with panthenol as cosurfactant to reduce skin irritation. doi:10.1016/j.ijpharm.2024.124585 PubMed
140. [140] Soorumsetty Ruthvik et al.. Cureus. 2024. Comparison of Efficacy of Platelet-Rich Plasma With and Without Topical Minoxidil for Hair Growth in Patients With Androgenetic Alopecia: A … doi:10.7759/cureus.53875 PubMed
141. [141] Amin Haghighat Naeini et al.. Int J Biol Macromol. 2024. Chitosan and its amphiphilic derivative nanoparticles loaded with Minoxidil for induction of hair growth: In vitro and in vivo evaluation. doi:10.1016/j.ijbiomac.2023.129122 PubMed
142. [142] Norihisa Kato et al.. Int J Mol Sci. 2024. Does Vitamin B6 Act as an Exercise Mimetic in Skeletal Muscle? doi:10.3390/ijms25189962 PubMed
143. [143] Linli Yu et al.. Arch Dermatol Res. 2024. Assessing the efficacy and quality of Life improvements of botulinum toxin type a with topical minoxidil versus topical minoxidil in … doi:10.1007/s00403-024-03258-9 PubMed
144. [144] Jia Yao et al.. PLoS One. 2024. The additive value of platelet-rich plasma to topical Minoxidil in the treatment of androgenetic alopecia: A systematic review and meta-analysis. doi:10.1371/journal.pone.0308986 PubMed
145. [145] Chuan Xiao et al.. Aesthetic Plast Surg. 2024. Meta-Analysis of Efficacy of Platelet-Rich Plasma Combined with Minoxidil for Androgenetic Alopecia. doi:10.1007/s00266-024-04054-6 PubMed
146. [146] Nutchaninad Tanuphol et al.. J Evid Based Integr Med. 2024. Effectiveness and Safety of Hair Growth Formulation Containing Tectona grandis L.f (Teak) Leaf Extract: A Randomized, Double-Blind, Placebo-Controlled Study on … doi:10.1177/2515690X241291141 PubMed
147. [147] Aarushi K Parikh et al.. Life (Basel). 2024. Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia. doi:10.3390/life14121577 PubMed
148. [148] Deesha D Desai et al.. Arch Dermatol Res. 2024. Comparative analysis of low-dose oral minoxidil with spironolactone versus finasteride or dutasteride in female androgenetic alopecia management. doi:10.1007/s00403-024-03361-x PubMed
149. [149] Nina Mehta et al.. J Cosmet Dermatol. 2024. Minoxidil sulfotransferase enzymatical activity in plants: A novel paradigm in increasing minoxidil response in androgenetic alopecia. doi:10.1111/jocd.15980 PubMed
150. [150] Ghada Alhayaza et al.. Dermatol Reports. 2024. Topical minoxidil reported hair discoloration: a cross-sectional study. doi:10.4081/dr.2023.9745 PubMed
151. [151] Esraa M Aledani et al.. Cureus. 2024. Mesotherapy as a Promising Alternative to Minoxidil for Androgenetic Alopecia: A Systematic Review. doi:10.7759/cureus.59705 PubMed
152. [152] Adriana C Corrêa et al.. Arch Dermatol Res. 2024. Split-scalp pilot study to evaluate effectiveness of Minoxidil 0,5% MMP® versus Topical Minoxidil 5% in the treatment of Female Pattern … doi:10.1007/s00403-024-03053-6 PubMed
153. [153] Vaibhav Kumar et al.. J Cosmet Dermatol. 2024. "Effectiveness of minimally invasive injectable modalities in the management of androgenetic alopecia among adults-A systematic review". doi:10.1111/jocd.16493 PubMed
154. [154] Arveen Shokravi et al.. SAGE Open Med Case Rep. 2024. Facial hair enhancement with minoxidil-an off-label use. doi:10.1177/2050313X241231490 PubMed
155. [155] Kara Adistri et al.. Dermatol Reports. 2024. Effectiveness and safety of the combination therapy of micro-needling and minoxidil in androgenetic alopecia of Indonesian men: a randomized controlled … doi:10.4081/dr.2024.9945 PubMed
156. [156] Xuefei Zhang et al.. Int J Nanomedicine. 2024. Resveratrol-Loaded Versatile Nanovesicle for Alopecia Therapy via Comprehensive Strategies. doi:10.2147/IJN.S477820 PubMed
157. [157] Deesha D Desai et al.. Arch Dermatol Res. 2024. Assessing low-dose oral minoxidil efficacy in androgenetic alopecia: a comparative study of AGA and AGA unmasked by telogen effluvium. doi:10.1007/s00403-024-03257-w PubMed
158. [158] Nazia Asad et al.. J Drugs Dermatol. 2024. Efficacy of Topical Finasteride 0.25% With Minoxidil 5% Versus Topical Minoxidil 5% Alone in Treatment of Male Pattern Androgenic Alopecia. doi:10.36849/JDD.7826 PubMed
159. [159] V P Erichev et al.. Vestn Oftalmol. 2024. [Minoxidil-induced ophthalmic hypertension (case report)]. doi:10.17116/oftalma202414002290 PubMed
160. [160] Ralph Green et al.. Food Nutr Bull. 2024. Vitamin B12 Deficiency in Clinical Practice-Proceedings of the International B12 Conference, June 2023, Rotterdam. doi:10.1177/03795721241228631 PubMed
161. [161] Eric Sanfilippo et al.. J Drugs Dermatol. 2024. Survey of Dermatology Practitioners' Opinions and Prescribing Habits of Oral Minoxidil for the Treatment of Androgenetic Alopecia. doi:10.36849/jdd.7519 PubMed
162. [162] Szymon Leonik et al.. Postepy Dermatol Alergol. 2024. Evaluation of the efficacy of microneedling without and with minoxidil 5% and autologous platelet-rich plasma for androgenetic alopecia in men. doi:10.5114/ada.2024.143496 PubMed
163. [163] Ambika Nohria et al.. JAAD Int. 2024. Improving efficacy and maintaining safety in the treatment of alopecia with low-dose oral minoxidil and spironolactone combination therapy: A retrospective … doi:10.1016/j.jdin.2024.07.023 PubMed
164. [164] Shivali Devjani et al.. Drugs. 2023. Androgenetic Alopecia: Therapy Update. doi:10.1007/s40265-023-01880-x PubMed
165. [165] Faiz-Ul Hassan et al.. Front Immunol. 2023. Potential of dietary hemp and cannabinoids to modulate immune response to enhance health and performance in animals: opportunities and challenges. doi:10.3389/fimmu.2023.1285052 PubMed
166. [166] Sincengile Ntshingila et al.. JAAD Int. 2023. Androgenetic alopecia: An update. doi:10.1016/j.jdin.2023.07.005 PubMed
167. [167] Michael Kaiser et al.. Clin Cosmet Investig Dermatol. 2023. Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs. doi:10.2147/CCID.S385861 PubMed
168. [168] Ruxuan Wang et al.. Small Methods. 2023. PROTAC Degraders of Androgen Receptor-Integrated Dissolving Microneedles for Androgenetic Alopecia and Recrudescence Treatment via Single Topical Administration. doi:10.1002/smtd.202201293 PubMed
169. [169] David Saceda-Corralo et al.. Am J Clin Dermatol. 2023. What's New in Therapy for Male Androgenetic Alopecia? doi:10.1007/s40257-022-00730-y PubMed
170. [170] Paulo Müller Ramos et al.. An Bras Dermatol. 2023. Female-pattern hair loss: therapeutic update. doi:10.1016/j.abd.2022.09.006 PubMed
171. [171] Aditya K Gupta et al.. Skin Appendage Disord. 2023. Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review. doi:10.1159/000531890 PubMed
172. [172] Chaofan Wang et al.. Clin Cosmet Investig Dermatol. 2023. The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review. doi:10.2147/CCID.S398950 PubMed
173. [173] Julia L Gao et al.. J Am Acad Dermatol. 2023. Androgenetic alopecia in transgender and gender diverse populations: A review of therapeutics. doi:10.1016/j.jaad.2021.08.067 PubMed
174. [174] Guiyue Wang et al.. J Cosmet Dermatol. 2023. Treatment of androgenetic alopecia by exosomes secreted from hair papilla cells and the intervention effect of LTF. doi:10.1111/jocd.15890 PubMed
175. [175] Nathalie Y Ly et al.. J Am Acad Dermatol. 2023. Medical and procedural treatment of androgenetic alopecia - Where are we? doi:10.1016/j.jaad.2023.05.004 PubMed
176. [176] Parth S Bajoria et al.. Cureus. 2023. Comparing Current Therapeutic Modalities of Androgenic Alopecia: A Literature Review of Clinical Trials. doi:10.7759/cureus.42768 PubMed
177. [177] Brittany Feaster et al.. Arch Dermatol Res. 2023. Oral minoxidil use in androgenetic alopecia and telogen effluvium. doi:10.1007/s00403-022-02331-5 PubMed
178. [178] Parsa Abdi et al.. Arch Dermatol Res. 2023. Efficacy and safety of combinational therapy using topical minoxidil and microneedling for the treatment of androgenetic alopecia: a systematic review … doi:10.1007/s00403-023-02688-1 PubMed
179. [179] Aqin Yan et al.. Int J Pharm. 2023. Co-delivery of minoxidil and tocopherol acetate ethosomes to reshape the hair Follicular Microenvironment and promote hair regeneration in androgenetic alopecia. doi:10.1016/j.ijpharm.2023.123498 PubMed
180. [180] Brendon Roets. Mater Today Bio. 2023. Potential application of PBM use in hair follicle organoid culture for the treatment of androgenic alopecia. doi:10.1016/j.mtbio.2023.100851 PubMed
181. [181] Ashling Courtney et al.. Expert Opin Pharmacother. 2023. Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia. doi:10.1080/14656566.2023.2280630 PubMed
182. [182] Niloufar Najar Nobari et al.. Adv Clin Exp Med. 2023. A systematic review of clinical trials using single or combination therapy of oral or topical finasteride for women in reproductive … doi:10.17219/acem/157990 PubMed
183. [183] Dharm Mansukh Sondagar et al.. Int J Trichology. 2023. Efficacy of Low-Level Laser Therapy in Androgenetic Alopecia - A Randomized Controlled Trial. doi:10.4103/ijt.ijt_5_22 PubMed
184. [184] Akshunna Keerti et al.. Cureus. 2023. Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women. doi:10.7759/cureus.44949 PubMed
185. [185] Francielle de Fátima Viana Santana et al.. Toxicol Appl Pharmacol. 2023. Comparative effects of finasteride and minoxidil on the male reproductive organs: A systematic review of in vitro and in vivo … doi:10.1016/j.taap.2023.116710 PubMed
186. [186] Sultan Pulat et al.. Pharmaceutics. 2023. Topical Delivery of Atraric Acid Derived from Stereocaulon japonicum with Enhanced Skin Permeation and Hair Regrowth Activity for Androgenic Alopecia. doi:10.3390/pharmaceutics15020340 PubMed
187. [187] Jeffrey Rapaport et al.. J Drugs Dermatol. 2023. Real-World, Open-Label Study of the Efficacy and Safety of a Novel Serum in Androgenetic Alopecia. doi:10.36849/JDD.7403 PubMed
188. [188] Celina Dubin et al.. JAAD Case Rep. 2023. Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer. doi:10.1016/j.jdcr.2023.02.021 PubMed
189. [189] Aditya K Gupta et al.. Skin Appendage Disord. 2023. Relative Effects of Minoxidil 5%, Platelet-Rich Plasma, and Microneedling in Pattern Hair Loss: A Systematic Review and Network Meta-Analysis. doi:10.1159/000534196 PubMed
190. [190] S Cedirian et al.. J Cosmet Dermatol. 2023. Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic … doi:10.1111/jocd.15873 PubMed
191. [191] Sara D Ragi et al.. JAAD Int. 2023. Evaluation of hair regrowth after minoxidil and dutasteride tattooing in men with androgenetic alopecia. doi:10.1016/j.jdin.2023.04.011 PubMed
192. [192] Satyendra K Singh et al.. Indian J Dermatol Venereol Leprol. 2023. Effect of platelet counts and activator in platelet-rich plasma on the treatment of androgenetic alopecia, split-head comparison: A randomised, double-blind … doi:10.25259/IJDVL_1254_20 PubMed
193. [193] Tiago Fernandes Gomes et al.. J Dtsch Dermatol Ges. 2023. Pediatric androgenetic alopecia: an updated review. doi:10.1111/ddg.14940 PubMed
194. [194] Michael A Kaiser et al.. J Cutan Aesthet Surg. 2023. Platelet Rich Plasma Combination Therapies for Treatment of Androgenetic Alopecia: A Systematic Review. doi:10.4103/JCAS.JCAS_206_22 PubMed
195. [195] Pooja Agarwal et al.. Int J Trichology. 2023. Platelet-Rich Plasma in Androgenetic Alopecia: Is It Really Worth the Hype? doi:10.4103/ijt.ijt_31_21 PubMed
196. [196] Kiran Godse et al.. Int J Trichology. 2023. Low-dose Oral Minoxidil in the Treatment of Alopecia: Evidence and Experience-based Consensus Statement of Indian Experts. doi:10.4103/ijt.ijt_70_23 PubMed
197. [197] Reese Imhof et al.. JAAD Int. 2023. Safety and tolerability of low dose oral minoxidil monotherapy in female pattern hair loss: A retrospective review with longitudinal ambulatory … doi:10.1016/j.jdin.2023.08.002 PubMed
198. [198] Michela Starace et al.. Ital J Dermatol Venerol. 2023. Oral supplementation in female telogen effluvium: a clinical and instrumental objective evidence of efficacy and tolerability of new oral cosmetic … doi:10.23736/S2784-8671.22.07416-3 PubMed
199. [199] Shreya Deoghare et al.. J Cosmet Laser Ther. 2023. Combination therapy in female pattern hair loss. doi:10.1080/14764172.2023.2222942 PubMed
200. [200] Daranporn Triwongwaranat et al.. Medicine (Baltimore). 2023. Characteristics of hair loss in COVID-19 patients in Thailand. doi:10.1097/MD.0000000000036539 PubMed
201. [201] Lina Alhanshali et al.. Dermatol Surg. 2023. Intradermal Delivery of Alopecia Therapeutics: Current State and Future Prospects. doi:10.1097/DSS.0000000000003866 PubMed
202. [202] Monica Păun et al.. Medicina (Kaunas). 2023. Epidemiologic Study of Gene Distribution in Romanian and Brazilian Patients with Non-Cicatricial Alopecia. doi:10.3390/medicina59091654 PubMed
203. [203] Li Hu et al.. BMJ Case Rep. 2023. Inverse androgenic alopecia. doi:10.1136/bcr-2022-254361 PubMed
204. [204] Jordan Sand et al.. Clin Plast Surg. 2023. Noninvasive Hair Rejuvenation. doi:10.1016/j.cps.2022.12.015 PubMed
205. [205] Kaneez Fatima et al.. Ann Med Surg (Lond). 2023. Novel vs. modified platelet-rich plasma therapy for hair loss treatment: a systematic review and meta-analysis. doi:10.1097/MS9.0000000000000396 PubMed
206. [206] Houfar Sekhavat et al.. Int J Trichology. 2023. TH07 - A New Novel Topical Treatment for Androgenic Alopecia. doi:10.4103/ijt.ijt_145_22 PubMed
207. [207] Leonardo de Medeiros Quirino et al.. Int J Trichology. 2023. Growth Factor Cocktail Including Fibroblast Growth Factor 9 (Cellcurin) in the Treatment of Androgenetic Alopecia in Men and Women: A … doi:10.4103/ijt.ijt_39_21 PubMed
208. [208] A K Gupta et al.. J Dermatolog Treat. 2022. Minoxidil: a comprehensive review. doi:10.1080/09546634.2021.1945527 PubMed
209. [209] Aditya K Gupta et al.. J Dermatolog Treat. 2022. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia. doi:10.1080/09546634.2022.2109567 PubMed
210. [210] Aditya K Gupta et al.. JAMA Dermatol. 2022. Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis. doi:10.1001/jamadermatol.2021.5743 PubMed
211. [211] Warintorn Ruksiriwanich et al.. Plants (Basel). 2022. Phytochemical Constitution, Anti-Inflammation, Anti-Androgen, and Hair Growth-Promoting Potential of Shallot (Allium ascalonicum L.) Extract. doi:10.3390/plants11111499 PubMed
212. [212] Dmitri Wall et al.. Fac Rev. 2022. Advances in hair growth. doi:10.12703/r/11-1 PubMed
213. [213] Robert S English et al.. Dermatol Ther (Heidelb). 2022. Microneedling and Its Use in Hair Loss Disorders: A Systematic Review. doi:10.1007/s13555-021-00653-2 PubMed
214. [214] Aditya K Gupta et al.. Dermatol Ther. 2022. Natural products for male androgenetic alopecia. doi:10.1111/dth.15323 PubMed
215. [215] Aditya K Gupta et al.. J Dermatolog Treat. 2022. Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment … doi:10.1080/09546634.2020.1749547 PubMed
216. [216] Talagavadi Channaiah Anudeep et al.. Pharmaceutics. 2022. Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia. doi:10.3390/pharmaceutics14030612 PubMed
217. [217] Aditya K Gupta et al.. J Cosmet Dermatol. 2022. Microneedling for Hair Loss. doi:10.1111/jocd.14525 PubMed
218. [218] Linlin Bao et al.. J Dermatolog Treat. 2022. Randomized trial of electrodynamic microneedling combined with 5% minoxidil topical solution for treating androgenetic alopecia in Chinese males and molecular … doi:10.1080/09546634.2020.1770162 PubMed
219. [219] Aditya K Gupta et al.. J Cosmet Dermatol. 2022. Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative? doi:10.1111/jocd.14895 PubMed
220. [220] Vanuchawan Wisuitiprot et al.. Sci Rep. 2022. Effects of Acanthus ebracteatus Vahl. extract and verbascoside on human dermal papilla and murine macrophage. doi:10.1038/s41598-022-04966-w PubMed
221. [221] Silvia Tampucci et al.. Pharmaceutics. 2022. Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to the Hair Follicle. doi:10.3390/pharmaceutics14020286 PubMed
222. [222] Raquel de Melo Carvalho et al.. J Cosmet Dermatol. 2022. Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know. doi:10.1111/jocd.14773 PubMed
223. [223] Kai Tian et al.. J Cosmet Dermatol. 2022. A study of combination unilateral subcutaneous botulinum toxin a treatment for androgenetic alopecia. doi:10.1111/jocd.15179 PubMed
224. [224] Dong Wook Shin. Korean J Physiol Pharmacol. 2022. The physiological and pharmacological roles of prostaglandins in hair growth. doi:10.4196/kjpp.2022.26.6.405 PubMed
225. [225] Laxman Subedi et al.. Drug Deliv. 2022. Preparation of topical bimatoprost with enhanced skin infiltration and in vivo hair regrowth efficacy in androgenic alopecia. doi:10.1080/10717544.2022.2027046 PubMed
226. [226] Pietro Gentile et al.. J Plast Reconstr Aesthet Surg. 2022. Systematic review: The platelet-rich plasma use in female androgenetic alopecia as effective autologous treatment of regenerative plastic surgery. doi:10.1016/j.bjps.2021.11.004 PubMed
227. [227] Belen de Nicolas-Ruanes et al.. J Am Acad Dermatol. 2022. Low-dose oral minoxidil for treatment of androgenetic alopecia and telogen effluvium in a pediatric population: A descriptive study. doi:10.1016/j.jaad.2022.04.030 PubMed
228. [228] Manabu Ohyama et al.. J Dermatol. 2022. Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better … doi:10.1111/1346-8138.16475 PubMed
229. [229] Khushbakht Saleem et al.. AAPS PharmSciTech. 2022. Exploiting Recent Trends in the Treatment of Androgenic Alopecia through Topical Nanocarriers of Minoxidil. doi:10.1208/s12249-022-02444-0 PubMed
230. [230] Daniel Fernandes Melo et al.. Dermatol Ther. 2022. Frontal edema due to mesotherapy for androgenetic alopecia: A case series. doi:10.1111/dth.15247 PubMed
231. [231] Rachita Dhurat et al.. J Cosmet Dermatol. 2022. SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth. doi:10.1111/jocd.14299 PubMed
232. [232] Peter R Feldman et al.. Front Med (Lausanne). 2022. Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis. doi:10.3389/fmed.2022.998623 PubMed
233. [233] Xuelei Liang et al.. Front Med (Lausanne). 2022. Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: … doi:10.3389/fmed.2022.905140 PubMed
234. [234] E Sánchez-Meza et al.. J Eur Acad Dermatol Venereol. 2022. Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo-controlled study. doi:10.1111/jdv.18285 PubMed
235. [235] Ghada F R Hassan et al.. J Cosmet Dermatol. 2022. Treatment with oral vitamin D alone, topical minoxidil, or combination of both in patients with female pattern hair loss: A … doi:10.1111/jocd.14743 PubMed
236. [236] Shreya Singh et al.. Clin Exp Dermatol. 2022. Does topical minoxidil at concentrations higher than 5% provide additional clinical benefit? doi:10.1111/ced.15338 PubMed
237. [237] Natalie Haddad et al.. J Drugs Dermatol. 2022. Evaluating the Efficacy of Platelet Rich Plasma and 1550 nm Fractional Laser in Combination and Alone for the Management of … doi:10.36849/JDD.6750 PubMed
238. [238] Laila Susanti et al.. Pharmaceuticals (Basel). 2022. Anti-Alopecia Activity of Alkaloids Group from Noni Fruit against Dihydrotestosterone-Induced Male Rabbits and Its Molecular Mechanism: In Vivo and In … doi:10.3390/ph15121557 PubMed
239. [239] Jay D Modha et al.. J Cosmet Dermatol. 2022. Comprehensive review of oral minoxidil in alopecia. doi:10.1111/jocd.15324 PubMed
240. [240] Xiangru Chen et al.. Front Bioeng Biotechnol. 2022. Bioengineered polyester nanoparticles for the synergistic treatment of androgenic alopecia via the suppression of 5α-reductase and knockdown of androgen receptor. doi:10.3389/fbioe.2022.1033987 PubMed
241. [241] Sara Abdel Gawad Elsebay et al.. Tissue Cell. 2022. Comparative histological and immunohistochemical study on the effect of platelet rich plasma/minoxidil, alone or in combination, on hair growth in … doi:10.1016/j.tice.2021.101726 PubMed
242. [242] Kathie P Huang et al.. JAMA Dermatol. 2022. Hair Are the Rankings-5-α Reductase Inhibitors and Minoxidil in Male Androgenetic Alopecia. doi:10.1001/jamadermatol.2021.5625 PubMed
243. [243] Fan Zhang et al.. Clin Cosmet Investig Dermatol. 2022. Observation on the Efficacy of a Combined Treatment for Moderate and Severe Androgenetic Alopecia Incorporating Electric Microneedles. doi:10.2147/CCID.S383289 PubMed
244. [244] Palash Sahu et al.. Cureus. 2022. Biomaterials for Treatment of Baldness. doi:10.7759/cureus.31187 PubMed
245. [245] Karolina Kozicka et al.. Postepy Dermatol Alergol. 2022. Scalp vascularization as a marker of topical minoxidil treatment efficacy in patients with androgenetic alopecia. doi:10.5114/ada.2021.103301 PubMed
246. [246] Lingling Jia et al.. J Cosmet Dermatol. 2022. Effects of microneedling with 5% minoxidil topical solution combination therapy in treatment of androgenetic alopecia. doi:10.1111/jocd.15263 PubMed
247. [247] Jordan Sand et al.. Facial Plast Surg Clin North Am. 2022. Noninvasive Hair Rejuvenation. doi:10.1016/j.fsc.2022.03.015 PubMed
248. [248] Mark S Nestor et al.. J Cosmet Dermatol. 2021. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. doi:10.1111/jocd.14537 PubMed
249. [249] Michael Randolph et al.. J Am Acad Dermatol. 2021. Oral minoxidil treatment for hair loss: A review of efficacy and safety. doi:10.1016/j.jaad.2020.06.1009 PubMed
250. [250] Sergio Vañó-Galván et al.. J Am Acad Dermatol. 2021. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. doi:10.1016/j.jaad.2021.02.054 PubMed
251. [251] A Villani et al.. J Eur Acad Dermatol Venereol. 2021. Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose. doi:10.1111/jdv.17216 PubMed
252. [252] Masoumeh Roohaninasab et al.. Dermatol Ther. 2021. Systematic review of platelet-rich plasma in treating alopecia: Focusing on efficacy, safety, and therapeutic durability. doi:10.1111/dth.14768 PubMed
253. [253] Jisha K Pillai et al.. J Cutan Aesthet Surg. 2021. Role of Low-Level Light Therapy (LLLT) in Androgenetic Alopecia. doi:10.4103/JCAS.JCAS_218_20 PubMed
254. [254] Jacob Griggs et al.. J Am Acad Dermatol. 2021. Pediatric androgenetic alopecia: A review. doi:10.1016/j.jaad.2019.08.018 PubMed
255. [255] Gita Faghihi et al.. J Cosmet Dermatol. 2021. Microneedling in androgenetic alopecia; comparing two different depths of microneedles. doi:10.1111/jocd.13714 PubMed
256. [256] Bevin Bhoyrul et al.. JAMA Dermatol. 2021. Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors. doi:10.1001/jamadermatol.2021.3676 PubMed
257. [257] Ibrahim M Ibrahim et al.. J Cosmet Dermatol. 2021. Pumpkin seed oil vs. minoxidil 5% topical foam for the treatment of female pattern hair loss: A randomized comparative trial. doi:10.1111/jocd.13976 PubMed
258. [258] Santo Raffaele Mercuri et al.. Medicina (Kaunas). 2021. Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment for Female Androgenetic Alopecia: Review of the Literature. doi:10.3390/medicina57040311 PubMed
259. [259] Wafaa Mohammad Ramadan et al.. J Cosmet Dermatol. 2021. Evaluation of adding platelet-rich plasma to combined medical therapy in androgenetic alopecia. doi:10.1111/jocd.13935 PubMed
260. [260] Vani Yepuri et al.. J Cutan Aesthet Surg. 2021. Platelet-Rich Plasma with Microneedling in Androgenetic Alopecia: Study of Efficacy of the Treatment and the Number of Sessions Required. doi:10.4103/JCAS.JCAS_33_20 PubMed
261. [261] Fernanda Ferrara et al.. Lasers Surg Med. 2021. Efficacy of Minoxidil Combined With Photobiomodulation for the Treatment of Male Androgenetic Alopecia. A Double-Blind Half-Head Controlled Trial. doi:10.1002/lsm.23411 PubMed
262. [262] Peter R Feldman et al.. EClinicalMedicine. 2021. Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial. doi:10.1016/j.eclinm.2021.100978 PubMed
263. [263] S Martínez-Pizarro. Actas Dermosifiliogr (Engl Ed). 2021. Low-Level Laser Therapy for Androgenetic Alopecia. doi:10.1016/j.ad.2020.03.010 PubMed
264. [264] Jun Fujita. J Cosmet Dermatol. 2021. Favorable effects of microneedling on long-standing androgenetic alopecia in an elderly man: A case report. doi:10.1111/jocd.13526 PubMed
265. [265] T Moreau et al.. Rev Med Liege. 2021. [A new treatment for androgenetic alopecia : platelet-rich plasma injections]. PubMed
266. [266] Katherine York et al.. Expert Opin Pharmacother. 2020. A review of the treatment of male pattern hair loss. doi:10.1080/14656566.2020.1721463 PubMed
267. [267] Pietro Gentile et al.. Int J Mol Sci. 2020. Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil®, Finasteride®, and Adult Stem Cell-Based Therapy. doi:10.3390/ijms21082702 PubMed
268. [268] Michela Starace et al.. Am J Clin Dermatol. 2020. Female Androgenetic Alopecia: An Update on Diagnosis and Management. doi:10.1007/s40257-019-00479-x PubMed
269. [269] Wimolsiri Iamsumang et al.. Drug Des Devel Ther. 2020. Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date. doi:10.2147/DDDT.S240615 PubMed
270. [270] Ajay N Sharma et al.. Int J Dermatol. 2020. Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review. doi:10.1111/ijd.14933 PubMed
271. [271] Sonia Sofia Ocampo-Garza et al.. Dermatol Ther. 2020. Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature. doi:10.1111/dth.14267 PubMed
272. [272] Alison J Bruce et al.. Dermatol Surg. 2020. A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women. doi:10.1097/DSS.0000000000002168 PubMed
273. [273] Pratiksha Kochar et al.. Cutan Ocul Toxicol. 2020. Exploring the potential of minoxidil tretinoin liposomal based hydrogel for topical delivery in the treatment of androgenic alopecia. doi:10.1080/15569527.2019.1694032 PubMed
274. [274] Sumel Ashique et al.. Nat Prod Bioprospect. 2020. A Systemic Review on Topical Marketed Formulations, Natural Products, and Oral Supplements to Prevent Androgenic Alopecia: A Review. doi:10.1007/s13659-020-00267-9 PubMed
275. [275] Maira Elizabeth Herz-Ruelas et al.. Skin Appendage Disord. 2020. Efficacy of Intralesional and Oral Dutasteride in the Treatment of Androgenetic Alopecia: A Systematic Review. doi:10.1159/000510697 PubMed
276. [276] Jaime R Fields et al.. Dermatol Ther. 2020. Topical ketoconazole for the treatment of androgenetic alopecia: A systematic review. doi:10.1111/dth.13202 PubMed
277. [277] Yasmeen Jabeen Bhat et al.. Indian Dermatol Online J. 2020. Female Pattern Hair Loss-An Update. doi:10.4103/idoj.IDOJ_334_19 PubMed
278. [278] Yi Zhou et al.. Dermatol Ther. 2020. The effectiveness of combination therapies for androgenetic alopecia: A systematic review and meta-analysis. doi:10.1111/dth.13741 PubMed
279. [279] Li Chen et al.. Aesthetic Plast Surg. 2020. The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis. doi:10.1007/s00266-020-01621-5 PubMed
280. [280] Dustin H Marks et al.. Am J Clin Dermatol. 2020. Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris. doi:10.1007/s40257-019-00493-z PubMed
281. [281] Hassan Galadari et al.. Lasers Med Sci. 2020. Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia. doi:10.1007/s10103-020-02994-4 PubMed
282. [282] Dustin H Marks et al.. Dermatol Clin. 2020. Androgenetic Alopecia in Gender Minority Patients. doi:10.1016/j.det.2019.10.010 PubMed
283. [283] Tymon Tai et al.. Facial Plast Surg Clin North Am. 2020. Physiology and Medical Treatments for Alopecia. doi:10.1016/j.fsc.2020.01.004 PubMed
284. [284] Irina N Kondrakhina et al.. Diagnostics (Basel). 2020. Plasma Zinc Levels in Males with Androgenetic Alopecia as Possible Predictors of the Subsequent Conservative Therapy's Effectiveness. doi:10.3390/diagnostics10050336 PubMed
285. [285] Mohammad Ali Nilforooshzadeh et al.. J Cosmet Dermatol. 2020. Effective combination therapy with high concentration of Minoxidil and Carboxygas in resistant Androgenetic alopecia: Report of nine cases. doi:10.1111/jocd.13362 PubMed
286. [286] A Sharma et al.. J Biol Regul Homeost Agents. 2020. Microneedling improves minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. doi:10.23812/19-385-L-51 PubMed
287. [287] Solmaz Asnaashari et al.. Altern Ther Health Med. 2020. Herbal Medicines For Treatment of Androgenic Alopecia. PubMed
288. [288] Mahmoud Makki et al.. J Cosmet Laser Ther. 2020. Evaluation of the effect of autologous platelet-rich plasma on androgenic alopecia. doi:10.1080/14764172.2020.1827150 PubMed
289. [289] Cristina Pindado-Ortega et al.. Skin Appendage Disord. 2020. Prescribing Habits for Androgenic Alopecia among Dermatologists in Spain in 2019-2020: A Cross-Sectional Study. doi:10.1159/000509063 PubMed
290. [290] Poonkiat Suchonwanit et al.. Drug Des Devel Ther. 2019. Minoxidil and its use in hair disorders: a review. doi:10.2147/DDDT.S214907 PubMed
291. [291] Tatiele Katzer et al.. Dermatol Ther. 2019. Physiopathology and current treatments of androgenetic alopecia: Going beyond androgens and anti-androgens. doi:10.1111/dth.13059 PubMed
292. [292] J Stevens et al.. Int J Womens Dermatol. 2019. Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocol. doi:10.1016/j.ijwd.2018.08.004 PubMed
293. [293] Enrico Carmina et al.. J Clin Endocrinol Metab. 2019. Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. doi:10.1210/jc.2018-02548 PubMed
294. [294] Maria Yusuf Dhariwala et al.. J Cosmet Dermatol. 2019. An overview of herbal alternatives in androgenetic alopecia. doi:10.1111/jocd.12930 PubMed
295. [295] Juan Jimenez-Cauhe et al.. J Am Acad Dermatol. 2019. Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia. doi:10.1016/j.jaad.2019.04.054 PubMed
296. [296] Jenna R Stoehr et al.. Am J Clin Dermatol. 2019. Off-Label Use of Topical Minoxidil in Alopecia: A Review. doi:10.1007/s40257-018-0409-y PubMed
297. [297] Kuldeep Verma et al.. Int J Trichology. 2019. A Study to Compare the Efficacy of Platelet-rich Plasma and Minoxidil Therapy for the Treatment of Androgenetic Alopecia. doi:10.4103/ijt.ijt_64_18 PubMed
298. [298] Abhijeet Kumar Jha et al.. J Cosmet Dermatol. 2019. Platelet-rich plasma and microneedling improves hair growth in patients ofandrogenetic alopecia when used as an adjuvant to minoxidil. doi:10.1111/jocd.12864 PubMed
299. [299] Jorge Ocampo-Garza et al.. Expert Opin Investig Drugs. 2019. New drugs under investigation for the treatment of alopecias. doi:10.1080/13543784.2019.1568989 PubMed
300. [300] Michela Starace et al.. J Cosmet Dermatol. 2019. Platelet-rich plasma on female androgenetic alopecia: Tested on 10 patients. doi:10.1111/jocd.12550 PubMed
301. [301] Aseem Sharma et al.. Dermatol Ther. 2019. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. doi:10.1111/dth.12915 PubMed
302. [302] Prachi Chetankumar Gajjar et al.. Int J Trichology. 2019. Comparative Study between Mesotherapy and Topical 5% Minoxidil by Dermoscopic Evaluation for Androgenic Alopecia in Male: A Randomized Controlled Trial. doi:10.4103/ijt.ijt_89_18 PubMed
303. [303] Valiollah Hajhashemi et al.. Avicenna J Phytomed. 2019. Beneficial effects of pumpkin seed oil as a topical hair growth promoting agent in a mice model. doi:10.22038/AJP.2019.13463 PubMed
304. [304] Calvin T. Sung et al.. J Drugs Dermatol. 2019. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review. PubMed
305. [305] Angela Wipf et al.. J Cosmet Laser Ther. 2019. The rise of transcutaneous drug delivery for the management of alopecia: a review of existing literature and an eye towards … doi:10.1080/14764172.2018.1525743 PubMed
306. [306] Eduardo Anitua et al.. J Cosmet Dermatol. 2019. Platelet rich plasma for the management of hair loss: Better alone or in combination? doi:10.1111/jocd.12683 PubMed
307. [307] Motoko Maekawa et al.. Biosci Biotechnol Biochem. 2019. Thiosulfate promotes hair growth in mouse model. doi:10.1080/09168451.2018.1518705 PubMed
308. [308] Robert S English et al.. Dermatol Ther (Heidelb). 2019. Self-Assessments of Standardized Scalp Massages for Androgenic Alopecia: Survey Results. doi:10.1007/s13555-019-0281-6 PubMed
309. [309] Buse Güler et al.. J Perinat Med. 2019. An investigation of vitamin and mineral supplement recommendation among first-trimester pregnancies. doi:10.1515/jpm-2019-0178 PubMed
310. [310] Karolina Kozicka et al.. Pol Merkur Lekarski. 2019. Methods of treatment patients with androgenetic alopecia based on reference of Department of Dermatology in Cracow. PubMed
311. [311] V Kanti et al.. J Eur Acad Dermatol Venereol. 2018. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. doi:10.1111/jdv.14624 PubMed
312. [312] Rodney D Sinclair. Int J Dermatol. 2018. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. doi:10.1111/ijd.13838 PubMed
313. [313] G Fabbrocini et al.. Int J Womens Dermatol. 2018. Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review. doi:10.1016/j.ijwd.2018.05.001 PubMed
314. [314] Sung Won Lee et al.. J Drugs Dermatol. 2018. A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women. PubMed
315. [315] R M Fertig et al.. J Eur Acad Dermatol Venereol. 2018. Microneedling for the treatment of hair loss? doi:10.1111/jdv.14722 PubMed
316. [316] P Suchonwanit et al.. J Eur Acad Dermatol Venereol. 2018. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil … doi:10.1111/jdv.15171 PubMed
317. [317] Bu Young Choi. Int J Mol Sci. 2018. Hair-Growth Potential of Ginseng and Its Major Metabolites: A Review on Its Molecular Mechanisms. doi:10.3390/ijms19092703 PubMed
318. [318] A K Gupta et al.. J Eur Acad Dermatol Venereol. 2018. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis. doi:10.1111/jdv.15081 PubMed
319. [319] Lizeth Martinez-Jacobo et al.. Indian J Dermatol Venereol Leprol. 2018. Genetic and molecular aspects of androgenetic alopecia. doi:10.4103/ijdvl.IJDVL_262_17 PubMed
320. [320] Evan Darwin et al.. Lasers Med Sci. 2018. Low-level laser therapy for the treatment of androgenic alopecia: a review. doi:10.1007/s10103-017-2385-5 PubMed
321. [321] Motomu Manabe et al.. J Dermatol. 2018. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. doi:10.1111/1346-8138.14470 PubMed
322. [322] Andy Goren et al.. Dermatol Ther. 2018. Minoxidil in the treatment of androgenetic alopecia. doi:10.1111/dth.12686 PubMed
323. [323] Muriki K Kumar et al.. J Cutan Aesthet Surg. 2018. A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in … doi:10.4103/JCAS.JCAS_130_17 PubMed
324. [324] Erkin Pekmezci et al.. Med Arch. 2018. Proprietary Herbal Extract Downregulates the Gene Expression of IL-1α in HaCaT Cells: Possible Implications Against Nonscarring Alopecia. doi:10.5455/medarh.2018.72.136-140 PubMed
325. [325] Mauro Barbareschi. G Ital Dermatol Venereol. 2018. The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years. doi:10.23736/S0392-0488.17.05781-9 PubMed
326. [326] Ibrahim Najem et al.. J Cosmet Laser Ther. 2018. Use of low-level laser therapy in treatment of the androgenic alopecia, the first systematic review. doi:10.1080/14764172.2017.1400174 PubMed
327. [327] C Pindado-Ortega et al.. Actas Dermosifiliogr (Engl Ed). 2018. Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study. doi:10.1016/j.ad.2018.02.006 PubMed
328. [328] Linda Chan et al.. Aust J Gen Pract. 2018. Female pattern hair loss. doi:10.31128/AJGP-02-18-4498 PubMed
329. [329] Ji Hyun Lee et al.. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2018. Determination of illegal adulteration of dietary supplements with synthetic hair-growth compounds by UPLC and LC-Q-TOF/MS. doi:10.1080/19440049.2017.1401736 PubMed
330. [330] Areej Adil et al.. J Am Acad Dermatol. 2017. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. doi:10.1016/j.jaad.2017.02.054 PubMed
331. [331] T Grant Phillips et al.. Am Fam Physician. 2017. Hair Loss: Common Causes and Treatment. PubMed
332. [332] Esther J van Zuuren et al.. JAMA Dermatol. 2017. Interventions for Female Pattern Hair Loss. doi:10.1001/jamadermatol.2016.5790 PubMed
333. [333] Kaksha B Shah et al.. Int J Trichology. 2017. A Comparative Study of Microneedling with Platelet-rich Plasma Plus Topical Minoxidil (5%) and Topical Minoxidil (5%) Alone in Androgenetic Alopecia. doi:10.4103/ijt.ijt_75_16 PubMed
334. [334] Eshini Perera et al.. F1000Res. 2017. Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study. doi:10.12688/f1000research.11775.1 PubMed
335. [335] Tasleem Arif et al.. Curr Clin Pharmacol. 2017. Dutasteride in Androgenetic Alopecia: An Update. doi:10.2174/1574884712666170310111125 PubMed
336. [336] Marina Perper et al.. Lasers Med Sci. 2017. Efficacy of fractional lasers in treating alopecia: a literature review. doi:10.1007/s10103-017-2306-7 PubMed
337. [337] Rachita Dhurat et al.. Skin Pharmacol Physiol. 2017. An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% versus Minoxidil 5% Solution in Male … doi:10.1159/000481141 PubMed
338. [338] Aditya K Gupta et al.. Dermatol Surg. 2017. A Critical Assessment of the Evidence for Low-Level Laser Therapy in the Treatment of Hair Loss. doi:10.1097/DSS.0000000000000904 PubMed
339. [339] S Vañó-Galván et al.. Actas Dermosifiliogr. 2017. New Treatments for Hair Loss. doi:10.1016/j.ad.2016.11.010 PubMed
340. [340] Mansour Siavash et al.. J Res Pharm Pract. 2017. Comparing the Effects of Zinc Sulfate, Calcium Pantothenate, Their Combination and Minoxidil Solution Regimens on Controlling Hair Loss in Women: … doi:10.4103/jrpp.JRPP_17_17 PubMed
341. [341] Hyo-Jung Lee et al.. Arch Pharm Res. 2017. Preparation and in vivo evaluation of lecithin-based microparticles for topical delivery of minoxidil. doi:10.1007/s12272-017-0934-x PubMed
342. [342] Sung Jay Choe et al.. Ann Dermatol. 2017. Therapeutic Efficacy of a Combination Therapy of Topical 17α-Estradiol and Topical Minoxidil on Female Pattern Hair Loss: A Noncomparative, Retrospective … doi:10.5021/ad.2017.29.3.276 PubMed
343. [343] Marlene Rodrigues et al.. BMJ Case Rep. 2017. Androgenic alopecia: an entity to consider in adolescence. doi:10.1136/bcr-2017-220679 PubMed
344. [344] Rattapon Thuangtong et al.. J Med Assoc Thai. 2017. A Comparative Study between the Efficacy and Safety of 5% Minoxidil Solution and 5% Minoxidil Milky Lotion in the Treatment … PubMed
345. [345] Ph Paquet et al.. Rev Med Liege. 2017. [What is the value of low-energie lasers in the treatment of androgenetic alopecia ?]. PubMed
346. [346] Hans Wolff et al.. Dtsch Arztebl Int. 2016. The Diagnosis and Treatment of Hair and Scalp Diseases. doi:10.3238/arztebl.2016.0377 PubMed
347. [347] Sushilkumar Ramdasi et al.. J Stem Cells. 2016. Human Mesenchymal Stem Cell-Derived Conditioned Media for Hair Regeneration Applications. PubMed
348. [348] Michelangelo La Placa et al.. Skin Appendage Disord. 2016. Scalp Psoriasiform Contact Dermatitis with Acute Telogen Effluvium due to Topical Minoxidil Treatment. doi:10.1159/000441622 PubMed
349. [349] Esther J van Zuuren et al.. Cochrane Database Syst Rev. 2016. Interventions for female pattern hair loss. doi:10.1002/14651858.CD007628.pub4 PubMed
350. [350] Amy McMichael et al.. J Drugs Dermatol. 2016. Efficacy and Safety of Minoxidil 2% Solution in Combination With a Botanical Hair Solution in Women With Female Pattern Hair … PubMed
351. [351] Terrence C Keaney et al.. J Drugs Dermatol. 2016. Efficacy and Safety of Minoxidil 5% Foam in Combination With a Botanical Hair Solution in Men With Androgenic Alopecia. PubMed
352. [352] Rachita Dhurat et al.. Indian J Dermatol. 2015. Response to Microneedling Treatment in Men with Androgenetic Alopecia Who Failed to Respond to Conventional Therapy. doi:10.4103/0019-5154.156361 PubMed
353. [353] Yunes Panahi et al.. Skinmed. 2015. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial. PubMed
354. [354] Andy Goren et al.. Dermatol Ther. 2015. Clinical utility and validity of minoxidil response testing in androgenetic alopecia. doi:10.1111/dth.12164 PubMed
355. [355] Jay C Vary. Med Clin North Am. 2015. Selected Disorders of Skin Appendages--Acne, Alopecia, Hyperhidrosis. doi:10.1016/j.mcna.2015.07.003 PubMed
356. [356] Fernanda Torres et al.. Semin Cutan Med Surg. 2015. Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia. doi:10.12788/j.sder.2015.0142 PubMed
357. [357] Dimitrios Ioannides et al.. Curr Probl Dermatol. 2015. Female pattern hair loss. doi:10.1159/000369404 PubMed
358. [358] H Wolff. Internist (Berl). 2015. [Drug treatment of alopecia]. doi:10.1007/s00108-015-3763-3 PubMed
359. [359] Pinar Avci et al.. Lasers Surg Med. 2014. Low-level laser (light) therapy (LLLT) for treatment of hair loss. doi:10.1002/lsm.22170 PubMed
360. [360] Swapna S Khatu et al.. J Cutan Aesthet Surg. 2014. Platelet-rich plasma in androgenic alopecia: myth or an effective tool. doi:10.4103/0974-2077.138352 PubMed
361. [361] Ruchy Jain et al.. Expert Opin Ther Targets. 2014. Potential targets in the discovery of new hair growth promoters for androgenic alopecia. doi:10.1517/14728222.2014.922956 PubMed
362. [362] Andréia Munck et al.. Int J Trichology. 2014. Use of low-level laser therapy as monotherapy or concomitant therapy for male and female androgenetic alopecia. doi:10.4103/0974-7753.138584 PubMed
363. [363] Leyre Falto-Aizpurua et al.. Expert Opin Emerg Drugs. 2014. Emerging treatments in alopecia. doi:10.1517/14728214.2014.974550 PubMed
364. [364] Aditya K Gupta et al.. Skin Therapy Lett. 2014. 5% Minoxidil: treatment for female pattern hair loss. PubMed
365. [365] Shannon Famenini et al.. J Drugs Dermatol. 2014. Evidence for supplemental treatments in androgenetic alopecia. PubMed
366. [366] Muhsin A Aldhalimi et al.. ISRN Pharmacol. 2014. Promotive effect of topical ketoconazole, minoxidil, and minoxidil with tretinoin on hair growth in male mice. doi:10.1155/2014/575423 PubMed
367. [367] Nicolas Perez-Mora et al.. Dermatol Ther. 2014. Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implications. doi:10.1111/dth.12101 PubMed
368. [368] B M Piraccini et al.. G Ital Dermatol Venereol. 2014. Androgenetic alopecia. PubMed
369. [369] A Rossi et al.. G Ital Dermatol Venereol. 2014. Treatment for alopecia. PubMed
370. [370] Rachita Dhurat et al.. Int J Trichology. 2013. A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study. doi:10.4103/0974-7753.114700 PubMed
371. [371] Feroze Kaliyadan et al.. Indian J Dermatol Venereol Leprol. 2013. Androgenetic alopecia: an update. doi:10.4103/0378-6323.116730 PubMed
372. [372] Nusrat Banka et al.. Dermatol Clin. 2013. Pattern hair loss in men: diagnosis and medical treatment. doi:10.1016/j.det.2012.08.003 PubMed
373. [373] Nattaya Lourith et al.. J Cosmet Dermatol. 2013. Hair loss and herbs for treatment. doi:10.1111/jocd.12051 PubMed
374. [374] Ingrid Herskovitz et al.. Int J Endocrinol Metab. 2013. Female pattern hair loss. doi:10.5812/ijem.9860 PubMed
375. [375] Farouk M Sakr et al.. Drug Des Devel Ther. 2013. Preparation and evaluation of a multimodal minoxidil microemulsion versus minoxidil alone in the treatment of androgenic alopecia of mixed etiology: … doi:10.2147/DDDT.S43481 PubMed
376. [376] Aron G Nusbaum et al.. Facial Plast Surg Clin North Am. 2013. Nonsurgical therapy for hair loss. doi:10.1016/j.fsc.2013.04.003 PubMed
377. [377] Archana Singal et al.. Indian J Dermatol Venereol Leprol. 2013. Female pattern hair loss. doi:10.4103/0378-6323.116732 PubMed
378. [378] Hammad A Bhatti et al.. J Cosmet Dermatol. 2013. Hair restoration approaches for early onset male androgenetic alopecia. doi:10.1111/jocd.12047 PubMed
379. [379] Lauren L Levy et al.. Int J Womens Health. 2013. Female pattern alopecia: current perspectives. doi:10.2147/IJWH.S49337 PubMed
380. [380] K J McElwee et al.. Skin Therapy Lett. 2012. Promising therapies for treating and/or preventing androgenic alopecia. PubMed
381. [381] E J van Zuuren et al.. Br J Dermatol. 2012. Evidence-based treatments for female pattern hair loss: a summary of a Cochrane systematic review. doi:10.1111/j.1365-2133.2012.11166.x PubMed
382. [382] Esther J van Zuuren et al.. Cochrane Database Syst Rev. 2012. Interventions for female pattern hair loss. doi:10.1002/14651858.CD007628.pub3 PubMed
383. [383] Alfredo Rossi et al.. Recent Pat Inflamm Allergy Drug Discov. 2012. Minoxidil use in dermatology, side effects and recent patents. doi:10.2174/187221312800166859 PubMed
384. [384] Olga Boychenko et al.. Cutis. 2012. Finasteride in the treatment of female pattern (androgenic) alopecia: a case report and review of the literature. PubMed
385. [385] R Sinclair et al.. Br J Dermatol. 2011. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness. doi:10.1111/j.1365-2133.2011.10630.x PubMed
386. [386] A W Rafi et al.. ISRN Dermatol. 2011. Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA. doi:10.5402/2011/241953 PubMed
387. [387] Patrick Henry McDonough et al.. Cutis. 2011. Adolescent androgenic alopecia. PubMed
388. [388] Deepani Rathnayake et al.. Expert Opin Pharmacother. 2010. Male androgenetic alopecia. doi:10.1517/14656561003752730 PubMed
389. [389] Deepani Rathnayake et al.. Dermatol Clin. 2010. Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss. doi:10.1016/j.det.2010.03.011 PubMed
390. [390] Mahyar Ghanaat. South Med J. 2010. Types of hair loss and treatment options, including the novel low-level light therapy and its proposed mechanism. doi:10.1097/SMJ.0b013e3181ebcf71 PubMed
391. [391] Eric S Schweiger et al.. J Drugs Dermatol. 2010. Update on the pathogenesis, genetics and medical treatment of patterned hair loss. PubMed
392. [392] Shyam Behari Shrivastava. Indian J Dermatol Venereol Leprol. 2009. Diffuse hair loss in an adult female: approach to diagnosis and management. doi:10.4103/0378-6323.45215 PubMed
393. [393] Adel Alsantali et al.. Curr Opin Endocrinol Diabetes Obes. 2009. Androgens and hair loss. doi:10.1097/med.0b013e32832b100a PubMed
394. [394] Francisco M Camacho-Martínez. Semin Cutan Med Surg. 2009. Hair loss in women. doi:10.1016/j.sder.2009.01.001 PubMed
395. [395] Anne L Mounsey et al.. Am Fam Physician. 2009. Diagnosing and treating hair loss. PubMed
396. [396] Laleh A Bedocs et al.. Curr Opin Pediatr. 2008. Adolescent hair loss. doi:10.1097/MOP.0b013e328305e285 PubMed
397. [397] Satoshi Itami. Nihon Rinsho. 2008. [Hair follicle regeneration]. PubMed
398. [398] Noah Scheinfeld. Dermatol Online J. 2008. A review of hormonal therapy for female pattern (androgenic) alopecia. PubMed
399. [399] Nina Otberg et al.. Endocrinol Metab Clin North Am. 2007. Androgenetic alopecia. doi:10.1016/j.ecl.2007.03.004 PubMed
400. [400] Carlijn Hoedemaker et al.. Australas J Dermatol. 2007. Treatment of female pattern hair loss with a combination of spironolactone and minoxidil. doi:10.1111/j.1440-0960.2007.00332.x PubMed
401. [401] Quan Q Dinh et al.. Clin Interv Aging. 2007. Female pattern hair loss: current treatment concepts. PubMed
402. [402] N V Tsiskarishvili et al.. Georgian Med News. 2007. [Effectiveness of the treatment plan for androgenetic alopecia]. PubMed
403. [403] Malgorzata Olszewska et al.. J Drugs Dermatol. 2005. Effective treatment of female androgenic alopecia with dutasteride. PubMed
404. [404] Dow Stough et al.. Mayo Clin Proc. 2005. Psychological effect, pathophysiology, and management of androgenetic alopecia in men. doi:10.4065/80.10.1316 PubMed
405. [405] Martina Bienová et al.. Acta Dermatovenerol Alp Pannonica Adriat. 2005. Androgenetic alopecia and current methods of treatment. PubMed
406. [406] Ronette R Briefel et al.. Annu Rev Nutr. 2004. Secular trends in dietary intake in the United States. doi:10.1146/annurev.nutr.23.011702.073349 PubMed
407. [407] Anne W Lucky et al.. J Am Acad Dermatol. 2004. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. doi:10.1016/j.jaad.2003.06.014 PubMed
408. [408] V del Marmol et al.. Rev Med Brux. 2004. [Androgenetic alopecia]. PubMed
409. [409] Vera H Price. J Investig Dermatol Symp Proc. 2003. Androgenetic alopecia in women. doi:10.1046/j.1523-1747.2003.12168.x PubMed
410. [410] R M Trüeb. Praxis (Bern 1994). 2003. [Hair loss]. doi:10.1024/0369-8394.92.36.1488 PubMed
411. [411] C Carolyn Thiedke. Am Fam Physician. 2003. Alopecia in women. PubMed
412. [412] Vera H Price. Cutis. 2003. Androgenetic alopecia in adolescents. PubMed
413. [413] Karyn Springer et al.. Am Fam Physician. 2003. Common hair loss disorders. PubMed
414. [414] Elise A Olsen et al.. J Am Acad Dermatol. 2002. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia … doi:10.1067/mjd.2002.124088 PubMed
415. [415] Sujay Khandpur et al.. J Dermatol. 2002. Comparative efficacy of various treatment regimens for androgenetic alopecia in men. doi:10.1111/j.1346-8138.2002.tb00314.x PubMed
416. [416] M P Birch et al.. Clin Exp Dermatol. 2002. Female pattern hair loss. doi:10.1046/j.1365-2230.2002.01085.x PubMed
417. [417] Rodney D Sinclair et al.. Australas J Dermatol. 2002. Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia. doi:10.1046/j.1440-0960.2002.00620.x PubMed
418. [418] R M Trüeb. Ther Umsch. 2002. [Diffuse hair loss in women]. doi:10.1024/0040-5930.59.5.217 PubMed
419. [419] Ligia Brzezińska-Wcisło. Pol Merkur Lekarski. 2002. [Effect of minoxidil on hair growth in androgenic alopecia in women]. PubMed
420. [420] Justine A Ellis et al.. Expert Rev Mol Med. 2002. Androgenetic alopecia: pathogenesis and potential for therapy. doi:10.1017/S1462399402005112 PubMed
421. [421] J McMurray et al.. Eur J Heart Fail. 2001. Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice. doi:10.1016/s1388-9842(01)00173-8 PubMed
422. [422] V M Meidan et al.. Drugs. 2001. Treatments for androgenetic alopecia and alopecia areata: current options and future prospects. doi:10.2165/00003495-200161010-00006 PubMed
423. [423] C Bolduc et al.. Am J Clin Dermatol. 2000. Management of androgenetic alopecia. doi:10.2165/00128071-200001030-00002 PubMed
424. [424] D J Hogan et al.. South Med J. 2000. Male pattern baldness. PubMed
425. [425] R Hoffmann et al.. Eur J Dermatol. 2000. Current understanding of androgenetic alopecia. Part II: clinical aspects and treatment. PubMed
426. [426] M Sommer et al.. Int J Clin Pract. 1999. Therapeutic approaches to the management of common baldness. PubMed
427. [427] A Tosti et al.. Int J Dermatol. 1999. Androgenetic alopecia. doi:10.1046/j.1365-4362.1999.00002.x PubMed
428. [428] D T Scow et al.. Am Fam Physician. 1999. Medical treatments for balding in men. PubMed
429. [429] A Tosti et al.. J Eur Acad Dermatol Venereol. 1999. Management of androgenetic alopecia. PubMed
430. [430] M E Sawaya. J Cutan Med Surg. 1999. Androgenetic alopecia: overview. PubMed
431. [431] T F Cash. Br J Dermatol. 1999. The psychosocial consequences of androgenetic alopecia: a review of the research literature. doi:10.1046/j.1365-2133.1999.03030.x PubMed
432. [432] J Shapiro et al.. Dermatol Clin. 1998. Hair regrowth. Therapeutic agents. doi:10.1016/s0733-8635(05)70017-6 PubMed
433. [433] C Piérard-Franchimont et al.. Dermatology. 1998. Ketoconazole shampoo: effect of long-term use in androgenic alopecia. doi:10.1159/000017954 PubMed
434. [434] S Rand. J Am Acad Dermatol. 1997. Chronic telogen effluvium: potential complication for clinical trials in female androgenetic alopecia? doi:10.1016/s0190-9622(97)70099-9 PubMed
435. [435] E Esteve et al.. Ann Dermatol Venereol. 1997. [Androgenetic alopecia]. PubMed
436. [436] P Karam. Int J Dermatol. 1993. Topical minoxidil therapy for androgenic alopecia in the Middle East. The Middle-Eastern Topical Minoxidil Study Group. doi:10.1111/j.1365-4362.1993.tb02756.x PubMed
437. [437] T J Connors et al.. Australas J Dermatol. 1990. Australian trial of topical minoxidil and placebo in early male pattern baldness. doi:10.1111/j.1440-0960.1990.tb00644.x PubMed
438. [438] J H Barth. Drugs. 1988. Alopecia and hirsuties. Current concepts in pathogenesis and management. doi:10.2165/00003495-198835010-00005 PubMed
439. [439] J J Kassimir. J Am Acad Dermatol. 1987. Use of topical minoxidil as a possible adjunct to hair transplant surgery. A pilot study. doi:10.1016/s0190-9622(87)70088-7 PubMed
440. [440] A H van der Willigen et al.. Contact Dermatitis. 1987. Topical minoxidil sensitization in androgenic alopecia. doi:10.1111/j.1600-0536.1987.tb02644.x PubMed
441. [441] T A Tromovitch et al.. Head Neck Surg. 1985. Medical treatment of male pattern alopecia (androgenic alopecia). doi:10.1002/hed.2890070410 PubMed
442. [442] E E Vanderveen et al.. J Am Acad Dermatol. 1984. Topical minoxidil for hair regrowth. doi:10.1016/s0190-9622(84)70183-6 PubMed